Options for decreasing ocular toxicity in patients with glaucoma.
By Arkadiy Yadgarov, MD, and Reena A. Garg, MD
On The Horizon
New medications give fresh hope for treating glaucoma.
By Jason Bacharach, MD
Sustained-Release Drug Delivery: the Future of Glaucoma Treatment
Several devices are being investigated.
By Justin A. Schweitzer, OD, FAAO, and Mitch Ibach, OD, FAAO
Phaco-Goniosynechialysis: Tap, Sweep, and Tweep By Jonathan S. Myers, MD
A mainstay of glaucoma management today and tomorrow.
By Robert D. Fetchner, MD, and Albert S. Khouri, MD
From the Trenches
What is maximal medical therapy today? Three physicians share their thoughts.
By Howard Barnebey, MD; Carla J. Siegfried, MD; and Julia Song, MD
The Adherence Problem
Its scope and strategies for its reduction.
By Henry D. Jampel, MD, MHS
The Literature By Jonathan Paul, MD, and Sheila Sanders, MD
Glaucoma in the Octogenarian
Considerations in treating the advanced elderly.
By Samuel P. Solish, MD
Cataract Surgery Alone—an Underused Solution?
One of the most common ophthalmic surgical tools achieves more than its primary intended purpose.
By Nicholas Bell, MD
Suprachoroidal Access: the Next Big Thing?
This new class of devices will allow further customization of glaucoma therapy.
By Cynthia Mattox, MD
Gonioscopy Is Essential for MIGS
This critical skill set comprises more than docking the goniolens.
By Shakeel Shareef, MD
Tools of the Trade
Instruments essential to any successful trabeculectomy.
By Jon M. Ruderman, MD, and Sara R. Ghobraiel, MD
MIGS in Kids
Recent advances may reshape the traditional paradigm.
By Ta Chen Peter Chang, MD
The Results Are in: 2016 Film Festival Winner Announced
Congratulations to Shakeel Shareef, MD, the winner of the GT 2016 Film Festival.
To the FDA With Appreciation By Steven D. Vold, MD
The Literature By Leonard K. Seibold, MD; Malik Y. Kahook, MD; and Jeffrey R. SooHoo, MD
What Is the Real IOP?
Laboratory studies may help us better understand our clinical dilemmas.
By Dan Eisenberg, MD
Highlights of the 2016 ARVO Annual Meeting
Select research findings presented this year.
By Sze H. Wong, MD, and Albert S. Khouri, MD
News Feature: a New Option for Uveitis
Adalimumab, a rheumatology drug, offers hope to patients with this damaging inflammatory eye disease.
By Agustin L. Gonzalez, OD
Glaucoma After Corneal Limbal Stem Cell Transplantation By Ahmad A. Aref, MD; Kavitha R. Sivaramen, MD; and Ali R. Djalilian, MD
Foundations of a Great Physician By Linda Huang, MD
Ocular Surface Disease: Impact on Glaucoma Surgical Decision Making
The preoperative planning process is more complex and requires careful attention to the unique issues at play.
By Tony Realini, MD, MPH
The Dark Side of Medication
Many systemic and topical drugs can cause or worsen dry eye disease.
By Sarah Marshall, PhD, and Robert Noecker, MD, MBA
Tear Osmolarity in a Glaucoma Practice
The role of point-of-care testing in dry eye disease and glaucoma management.
By Leslie E. O’Dell, OD
The principles and clinical significance of various technologies.
By Alice T. Epitropoulos, MD
Intense Pulsed Light for Dry Eye Disease
This procedure improves the health of the meibomian glands.
By Rolando Toyos, MD
What Every Glaucoma Doctor Should Know About DED
New technologies provide more information and better outcomes than ever before.
By Sheri Rowen, MD
Punctal Occlusion and Ocular Nutrition By Paul S. Koch, MD, and Thandeka Myeni, MD, MPH
Neurostimulation: a Novel Approach to Treating the Signs and Symptoms of Dry Eye
A device in clinical study could lead to new understanding of dry eye as a neuronal disease.
By John Berdahl, MD
Being a Doctor, Thinking Like a CEO
The merging of two mindsets requires skill, versatility, and sensitivity.
By Wolfgang Riha, MD
The Literature By Reena A. Garg, MD, and Helen Jiang, MD
Detecting and Treating Glaucoma in a Myopic Patient Without High IOP By Robert Chang, MD, and Kuldev Singh, MD, MPH
The Eyes of Africa Project
Partners bring comprehensive eye care to rural Malawi.
By William Eric Sponsel, MD
Assessing Corneal Biomechanics
The importance of these properties rests primarily with their effects on IOP measurement.
By Leon W. Herndon, MD
Evaluating Quality of Life in Glaucoma
Understand the impact of the disease to improve care.
By Felipe A. Medeiros, MD, PhD
Do We Need Perimetry?
As glaucoma advances, visual field testing provides valuable insight.
By Murray Fingeret, OD